Drugs / EV71 inactivated enterovirus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06754384 Comparator | Jan → Dec 2025 | hand, foot and mouth disease, herpangina | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EV71 inactivated enterovirus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06754384 ↗ |
| Known as | EV71 inactivated enterovirus vaccine (Vero cell) | “EV71 inactivated enterovirus vaccine (Vero cell) )(for ages 6-71 months）” NCT06754384 ↗ |
| Modality | Vaccine | “EV71 inactivated enterovirus vaccine” NCT06754384 ↗ |